zabmedvestnikЗабайкальский медицинский вестникTransbaikalian Medical Bulletin1998-6173Читинская государственная медицинская академия10.52485/10.52485/19986173_2024_4_78zabmedvestnik-356Research ArticleНАУЧНЫЕ ОБЗОРЫSCIENTIFIC REVIEWSНАСЛЕДСТВЕННЫЕ ТРОМБОФИЛИИ И ТРИГГЕРЫ ТРОМБОТИЧЕСКИХ СОСТОЯНИЙ У ДЕТЕЙHEREDITARY THROMBOPHILIA AND TRIGGERS OF THROMBOTIC CONDITIONS IN CHILDRENhttps://orcid.org/0000-0001-8277-2669БогдановаА. С.BogdanovaA. S.

Богданова Анна Сергеевна, к.м.н., доцент, доцент кафедры госпитальной и факультетской педиатрии с курсом пропедевтики детских болезней

AuthorID: 721310 

Bogdanova A.S., Candidate of Medical Sciences, associate Professor, associate Professor of the Department of Hospital and Faculty Pediatrics with a course in Propaedeutics of childhood diseases

AuthorID: 721310 .

35 Muravyov-Amursky st., Khabarovsk, 680000

as_bogdanova@mail.ruФГБОУ ВО «Дальневосточный государственный медицинский университет» Министерства здравоохранения РФРоссияFar Eastern State Medical UniversityRussian Federation202425022025047885Copyright © Богданова А.С., 20252025Богданова А.С.Bogdanova A.S.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.zabmedvestnik.ru/jour/article/view/356

О склонности к патологическому тромбообразованию у детей говорят при наличии у них генов тромбофилий. Однако для формирования тромботического процесса необходим некий пусковой механизм. Известен целый ряд таких триггеров, достаточно хорошо изученных у взрослых пациентов, но среди детского населения информации мало. В статье приведен научный обзор по тромбофилии, представлены общие положения, освещены данные некоторых исследований российских и зарубежных авторов, акцент в статье сделан на тромботические состояния и триггеры у детей.

Children have thrombosis in the presence of thrombophilia genes. A trigger mechanism is needed for the thrombotic process. Triggers are known in adult patients, but there is little information in children. The article contains a scientific review on thrombophilia. The general provisions and data from some studies by Russian and foreign authors are described. The article focuses on thrombotic conditions and triggers in children.

тромбофилиятромбозгены тромбофилийтриггеры тромбообразованиядетиhrombophiliathrombosisthrombophilia genesthrombosis triggerschildrenReferencesBates S.M., Greer I.A., Pabinger I. et al. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). J. Chest. 2008. 133 (6). 844–886.Bates S.M., Greer I.A., Pabinger I. et al. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). J. Chest. 2008. 133 (6). Рр.844–886.Egeberg O. Inherited antithrombin deficiency causing thrombophilia. J. Thrombosis et Diathesis Haemorrhagica. 1965. 13. 16–46.Egeberg O. Inherited antithrombin deficiency causing thrombophilia. J. Thrombosis et Diathesis Haemorrhagica. 1965. 13. 16–46.Nicolaides A.N., Fareed J., Kakkar A.K. et al. Prevention and treatment of venous thromboembolism — International Consensus Statement. J. International Angiology. 2013. 32 (2). 111–260.Nicolaides A.N., Fareed J., Kakkar A.K. et al. Prevention and treatment of venous thromboembolism — International Consensus Statement. J. International Angiology. 2013. 32(2). 111–260.American College of Obstetricians and Gynecologists Women’s Health Care Physicians. ACOG Practice Bulletin No. 138: Inherited thrombophilias in pregnancy. J. Obstetetrics and Gynecology. 2013. 122 (3). 706–723.American College of Obstetricians and Gynecologists Women’s Health Care Physicians. ACOG Practice Bulletin No. 138: Inherited thrombophilias in pregnancy. J. Obstetetrics and Gynecology. 2013. 122 (3). 706–723.Dilley A., Austin H., Hooper W.C. et al. Prevalence of the prothrombin 20210 G-to-A variant in blacks: infants, patients with venous thrombosis, patients with myocardial infarction, and control subjects. J. of Laboratory and Clinical Medicine. 1998. 132 (6). 452–457.Dilley A., Austin H., Hooper W.C. et al. Prevalence of the prothrombin 20210 G-to-A variant in blacks: infants, patients with venous thrombosis, patients with myocardial infarction, and control subjects. J. of Laboratory and Clinical Medicine. 1998. 132 (6). 452–457.Rosendaal F.R., Doggen C.J., Zivelin A. et al. Geographic distribution of the 20210 G to A prothrombin variant. J. Thrombosis and Haemostasis. 1998. 79 (4). 706–714.Rosendaal F.R., Doggen C.J., Zivelin A. et al. Geographic distribution of the 20210 G to A prothrombin variant. J. Thrombosis and Haemostasis. 1998. 79 (4). 706–714.Капустин С.И., Блинов М.Н., Папаян Л.П., Селиванов Е.А. Наследственная тромбофилия — актуальная проблема современной медицины. Медицинский академический журнал. 2006. 6. 1. 83–91.Kapustin S.I., Blinov M.N., Papayan L.P., Selivanov E.A. Hereditary thrombophilia is a pressing problem in modern medicine. Meditsinskiy akademicheskiy zhurnal. 2006. 6. 1. 83–91. In Russian.Ridker P.M., Miletich J.P., Hennekens C.H., Buring J.E. Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening. J. JAMA pediatrics. 1997. 277 (16). 1305–1312.Ridker P.M., Miletich J.P., Hennekens C.H., Buring J.E. Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening. J. JAMA pediatrics. 1997. 277 (16). 1305–1312.Cooper D.N., Krawezak M. Venous thrombosis: from genes to clinical medicine. BIOS Scientific Publishers Ltd. 1997. 368.Cooper D.N., Krawezak M. Venous thrombosis: from genes to clinical medicine. BIOS Scientific Publishers Ltd. 1997. 368.Dizon-Townson D.S., Meline L., Nelson L.M. et al. Fetal carriers of the factor V Leiden mutation are prone to miscarriage and placental infarction. J. Obstetetrics and Gynecology. 1997. 177 (2). 402–408.Dizon-Townson D.S., Meline L., Nelson L.M. et al. Fetal carriers of the factor V Leiden mutation are prone to miscarriage and placental infarction. J. Obstetetrics and Gynecology. 1997. 177 (2) 402–408.Simone B., De Stefano V., Leoncini E. et al. Risk of venous thromboembolism associated with single and combined effects of factor V Leiden, prothrombin 20210A and methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls. Eur J. Epidemiology. 2013. 201. 28 (8). 621–668.Simone B., De Stefano V., Leoncini E. et al. Risk of venous thromboembolism associated with single and combined effects of factor V Leiden, prothrombin 20210A and methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls. Eur J. Epidemiology. 2013. 201. 28 (8). 621–668.Момот А.П. Проблема тромбофилии в клинической практике. Российский журнал детской гематологии и онкологии. 2015. 2 (1). 36–48.Momot A.P. The problem of thrombophilia in clinical practice. 2015. 2 (1). 36–48. In Russian.Chang M.H., Lindegren M.L., Butler M.A. et al. Prevalence in the United States of selected candidate gene variants: Third National Health and Nutrition Examination Survey 1991–1994. J. Epidemiology. 2009. 169 (1). 54–66.Chang M.H., Lindegren M.L., Butler M.A. et al. Prevalence in the United States of selected candidate gene variants: Third National Health and Nutrition Examination Survey, 1991–1994. J. Epidemiology. 2009. 169 (1). 54–66.Николаева М.Г., Момот А.П., Мамаев А.Н., Хорев Н.Г. и соавт. Тромботические события при редких формах генетических тромбофилий. Тромбоз, гемостаз и реология. 2020. 4. 87–94.Nikolaeva M.G., Momot A.P., Mamaev A.N., Khorev N.G. et al. Thrombotic events in rare forms of genetic thrombophilia. Tromboz, gemostaz i reologiya. 2020. 4. 87–94. In Russian.Строзенко Л.А., Гордеев В.В., Лобанов Ю.Ф., Момот А.П. Полиморфные варианты сочетаний генов системы гемостаза и фолатного цикла в популяции подростков Алтайского края. Российский педиатрический журнал. 2015. 18 (4). 26–31.Strozenko L.A., Gordeev V.V., Lobanov Yu.F., Momot A.P. et al. Distribution of polymorphic options of genes of blood coagulation factors and gents of the folate metabolism in adolescents of the Altai Krai. Rossiiskii Pediatricheskii Zhurnal. 2015.18(4). 26–31. In Russian.Ostlund A., Flaring U., Norberg A., Dahlberg A., Berner J. et al. Incidence of and risk factors for venous thrombosis in children with percutaneous non-tunnelled central venous catheters. Br J Anaesthesia. 2019. Sep. 123 (3). 316–324. https://pubmed.ncbi.nlm.nih.gov/31176448/ doi: 10.1016/j.bja.2019.04.055. Epub 2019 Jun 6.Ostlund A., Flaring U., Norberg A., Dahlberg A., Berner J. et al. Incidence of and risk factors for venous thrombosis in children with percutaneous non-tunnelled central venous catheters. Br J Anaesthesia. 2019. Sep. 123 (3). 316–324. https://pubmed.ncbi.nlm.nih.gov/31176448/ doi: 10.1016/j.bja.2019.04.055. Epub 2019 Jun 6.Шумакова О.В., Морозова Н.Я., Буров А.А. и соавт. Особенности гемостаза у детей с врожденными пороками сердца в первые 12 часов жизни. Вопросы гематологии, онкологии и иммунопатологии в педиатрии. 2019. 3. 29–34.Shumakova O.V., Morozova N.Ya., Burov A.A. et al. Features of hemostasis in children with congenital heart defects in the first 12 hours of life. Voprosy gematologii, onkologii i immunopatologii v pediatrii. 2019. 3. 29–34. In Russian.Кузник Б.И., Стуров В.Г., Максимова О.Г. Геморрагические и тромботические заболевания и синдромы у детей. Патогенез, клиника, диагностика, терапия и профилактика. Новосибирск. Наука. 2012.Kuznik B.I., Maksimova O.G., Sturov V.G. Hemorrhagic and thrombotic diseases and syndromes in children. Pathogenesis, clinical features, diagnostics, therapy and prevention. Novosibirsk: Nauka. 2012. In Russian.Солдатевникова Л.В., Комиссаров К.А., Солдатенков Е.В., Минаева М.В. и соавт. Тромбофилии у пациентов Северо-Западного региона России: классические и дополнительные факторы риска. Вестник гематологии. 2021. 17. 4. 59–60.Soldatevnikova L.V., Komissarov K.A., Soldatenkov E.V., Minaeva M.V. et al. Thrombophilia in patients of the North-West region of Russia: classical and additional risk factors. Vestnik gematologii. 2021. 17. 4. 59–60. In Russian.Стуров В.Г., Чупрова А.В., Анмут С.Я. Дисфибриногенемия: современное состояние проблемы диагностики, верификации, лечения. Тромбоз, гемостаз и реология. 2003. 4 (16). 24–30.Sturov V.G., Chuprova A.V., Anmut S.Ya.. Dysfibrinogenemia: current state of the problem of diagnosis, verification, treatment. Tromboz, gemostaz i reologiya. 2003. 4 (16). 24–30. In Russian.Spinillo A., Gardella B., Adamo L. et al. Pathologic placental lesions in early and late fetal growth restriction. Acta Obstet Gynecol Scand. 2019. 98 (12). 1585–94. https://pubmed.ncbi.nlm.nih.gov/31370094/ doi:10.1111/aogs.13699.Spinillo A., Gardella B., Adamo L. et al. Pathologic placental lesions in early and late fetal growth restriction. Acta Obstet Gynecol Scand. 2019. 98 (12). 1585–94. https://pubmed.ncbi.nlm.nih.gov/31370094/ doi: 10.1111/aogs.13699.Monagle P., Cuello K.A. Management of venous thromboembolism: treatment of pediatric venous thromboembolism. Blood. 2018. Nov 27. 2 (22). 3292–3316. https://translated.turbopages.org/proxy_u/en-ru.ru.ffdf233e-677bc5f2-8f574799-74722d776562/ https/pubmed.ncbi.nlm.nih.gov/30482766/ doi:10.1182/bloodadvances.2018024786.Monagle P., Cuello K.A. Management of venous thromboembolism: treatment of pediatric venous thromboembolism. Blood. 2018. Nov 27. 2 (22). 3292-3316. https://translated.turbopages.org/proxy_u/ en-ru.ru.ffdf233e-677bc5f2-8f574799-74722d776562/ https/pubmed.ncbi.nlm.nih.gov/30482766/ doi:10.1182/bloodadvances.2018024786.Костюченко Г.И., Баркаган З.С., Костюченко Л.А. Гипергомоцистеинемия: частота, возрастные особенности, методы коррекции у больных коронарной болезнью сердца. Тромбоз, гемостаз и реология. 2003. 3 (15). 33–36.Kostyuchenko G.I., Barkagan Z.S., Kostyuchenko L.A. Hyperhomocysteinemia: frequency, age characteristics, methods of correction in patients with coronary heart disease. Tromboz, gemostaz i reologiya. 2003. 3 (15). 33–36. In Russian.Жданова Л.В., Патрушев Л.И., Бимбаева А.Б.Ж. Наследственные тромбофилии как риск развития ишемических инсультов у детей. Вестник Бурятского государственного университета. Медицина и фармация. 2017. 1. 85–89.Zhdanova L.V., Patrushev L.I., Bimbaeva A.B.Zh. Hereditary thrombophilia as a risk factor for ischemic stroke in children. Vestnik Buryatskogo gosudarstvennogo universiteta. Meditsina i farmatsiya. 2017. 1. 85–89. In Russian.Подсвирова Е.В., Балакирева Е.А., Романова Т.А. и соавт. Случай ранней диагностики наследственной тромбофилии у ребенка 16 дней. Российский вестник перинатологии и педиатрии. 2019. 64 (3). 82–86.Podsvirova E.V., Balakireva E.A., Romanova T.A. et al. A case of early diagnosis of hereditary thrombophilia in a 16-day-old child. Rossiyskii vestnik perinatologii i pediatrii. 2019. 64 (3). 82–86. In Russian.Николаева М.Г. Репродуктивно значимая реализация мутации Лейден и персонифицированный подход к профилактике осложненного течения беременности: [диссертация Николаевой Марии Геннадьевны док. мед. наук]. Барнаул: «Алтайский государственный медицинский университет» МЗ РФ. 2018.Nikolaeva M.G. Reproductively significant implementation of the Leiden mutation and a personalized approach to the prevention of complicated pregnancy: [dissertatsiya Nikolaevoy Marii Gennad'evny dok. med. nauk]. Barnaul: «Altayskiy gosudarstvennyy meditsinskiy universitet» MZ RF. 2018. In Russian.Cohen W., Castelli C., Suchon P. et al. Risk assessment of venous thrombosis in families with known hereditary thrombophilia: the MARseilles-NImes prediction model. J. Thrombosis and Haemostasis. 2014. 12 (2). 138–184.Cohen W., Castelli C., Suchon P. et al. Risk assessment of venous thrombosis in families with known hereditary thrombophilia: the MARseilles-NImes prediction model. J. Thrombosis and Haemostasis. 2014. 12 (2). 138–184.Timp J.F., Braekkan S.K., Lijfering W.M. et al. Risk prediction of recurrent venous thrombosis; where are we now and what can we add? Journal of Thrombosis and Haemostasis. 2019. 17. 9. 1527–1534.Timp J.F., Braekkan S.K., Lijfering W.M. et al. Risk prediction of recurrent venous thrombosis; where are we now and what can we add? Journal of Thrombosis and Haemostasis. 2019. 17. 9. 1527–1534.Озолиня Л.А., Патрушев Л.И., Шполянская Ю.Ю. и соавт. Распространенность мутаций в генах фактора V (G1691 A Leiden), протромбина (G 20210A) и метилентетрагидрофолатредуктазы (С677Т) среди беременных и их связь с патологией. Тромбоз, гемостаз и реология. 2001. 1 (5). 47–53.Ozolinya L.A., Patrushev L.I., Shpolyanskaya Yu.Yu. et al. Prevalence of mutations in the genes of factor V (G1691 A Leiden), prothrombin (G 20210A) and methylenetetrahydrofolate reductase (C677T) among pregnant women and their association with pathology. Tromboz, gemostaz i reologiya. 2001. 1 (5). 47–53. In Russian.Идельсон Л.И., Альберт И.И., Руденский Б. Сочетание гетерозиготного носительства лейденской мутации фактора V свертывания крови с эритроцитозом как причина тромбоза глубоких вен бедра. Терапевтический архив. 2002. 2. 66–69.Idel'son L.I., Al'bert I.I., Rudenskiy B. et al. Combination of heterozygous carriage of the Leiden mutation of factor V blood coagulation with erythrocytosis as a cause of deep vein thrombosis of the thigh. Terapevticheskiy arkhiv. 2002. 2. 66–69. In Russian.Папаян Л.П., Папаян К.А., Ракова М.А. и соавт. Тромбоз как мультифакторное событие у детей на примере клинического случая. Вестник гематологии. 2019. 15. 3. 50–78.Papayan L.P., Papayan K.A., Rakova М.А. et al. Thrombosis as a multifactorial event in children on the example of a clinical case. Vestnik gematologii. 2019. 15. 3. 50–78. In Russian.Строзенко Л.А., Лобанов Ю.Ф., Колесникова М.А. и соавт. Факторы риска у детей с острыми нарушениями мозгового кровообращения по ишемическому типу. Педиатрия. Журнал имени Г.Н. Спиранского. 2020. 99. 2. 163–172.Strozenko L.A.,. Lobanov Yu.F, Kolesnikova M.A., Rychkova O.A., Tsyvkina L.P., Momot A.P. Risk factors in children with acute cerebral circulation disorders by ischemic type. Pediatria n.a. G.N. Speransky. 2020. 99 (2). 163–172. In Russian.Braekkan S. K., Mathiesen E.B., Njolstad I. et al. Hematocri t and risk of venous thromboembolism in a general population. The Tromso study. Haematologica. 2010. 95. 270–275.Braekkan S. K., Mathiesen E.B., Njolstad I. et al. Hematocri t and risk of venous thromboembolism in a general population. The Tromso study. Haematologica. 2010. 95. 270–275.Nowak-Göttl U., Ommen H., Kenet G. Thrombophilia testing in children: What and when should be tested? Author links open overlay panel. 2018. April. 164. 75-78. https://www.sciencedirect.com/science/article/abs/pii/S0049384818302019.Nowak-Göttl U., Ommen H., Kenet G. Thrombophilia testing in children: What and when should be tested? Author links open overlay panel. 2018. April. 164. 75-78. https://www.sciencedirect.com/science/article/abs/pii/S0049384818302019.Clark H.H., Ballester L., Whitworth H., Raffini L., Witmer Ch. Prevention of recurrent thrombotic events in children with central venous catheter-associated venous thrombosis. Blood. 2022. Jan 20. 139. (3). 452–460. https://www.sciencedirect.com/science/article/pii/S0006497121018206.Clark H.H., Ballester L., Whitworth H., Raffini L., Witmer Ch. Prevention of recurrent thrombotic events in children with central venous catheter-associated venous thrombosis. Blood. 2022. Jan 20. 139. (3). 452–460. https://www.sciencedirect.com/science/article/pii/S0006497121018206.Mahajerin A., Betensky M., Goldenberg N. A. Thrombosis in children: approach to anatomic risrks, thrombophilia, prevention, and treatment. Hematology/Oncology Clinics of North Amtrica. 2019. 33 (3). June. 439–453. https://www.sciencedirect.com/science/article/abs/pii/S0889858819300255.Mahajerin A., Betensky M., Goldenberg N. A. Thrombosis in children: approach to anatomic risrks, thrombophilia, prevention, and treatment. Hematology/Oncology Clinics of North Amtrica. 2019. 33 (3). June. 439–453. https://www.sciencedirect.com/science/article/abs/pii/S0889858819300255.Colucci G., Tsakiris D. A. Thrombophilia screening revisited: an issue of personalized medicine. J. Thromb Thrombolisis. 2020. May. 49 (4): 618–629. https://pubmed.ncbi.nlm.nih.gov/32248336/ doi: 10.1007/s1239-020-02090-y.G. Colucci, D. A. Tsakiris. Thrombophilia screening revisited: an issue of personalized medicine. J. Thromb Thrombolisis. 2020. May. 49 (4): 618–629. https://pubmed.ncbi.nlm.nih.gov/32248336/ doi: 10.1007/s1239-020-02090-y.ФГБУ «ФНКЦ ДГОИ имени Дмитрия Рогачева Минздрава России и Национальное общество детских гематологов, онкологов России. Федеральные клинические рекомендации по диагностике и лечению тромбозов у детей и подростков. М.: 2015. 50.Federal State Budgetary Institution "FNCC Dmitriy Rogachev DGOI of the Ministry of Health of the Russian Federation and the National Society of Pediatric Hematologists, Oncologists of Russia. Federal clinical guidelines for the diagnosis and treatment of thrombosis in children and adolescents. Moscow: 2015. 50. In Russian.

The authors declare that there are no conflicts of interest present.